Hologic Announces Financial Results for Fourth Quarter of Fiscal 2021
– Revenue of $1.317 Billion Exceeds Expectations – – Company Posts GAAP Diluted EPS of $1.28, Non-GAAP Diluted EPS of...
Day: November 1, 2021
Dr. Grace Valina Discusses Her Volunteer Work Abroad
Dr. Grace Valina Talks About Performing Surgeries Abroad and How Volunteering Has Shaped Her Professional ExperienceMIAMI, FL / ACCESSWIRE /...
Psyched Wellness Announces Participation in Microdose’s Wonderland: Miami on November 8-9, 2021
Toronto, Ontario--(Newsfile Corp. - November 1, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or...
Neovasc to Report Third Quarter 2021 Financial Results on November 9, 2021
Vancouver, British Columbia--(Newsfile Corp. - November 1, 2021) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN), will report financial results for the...
My Secure Advantage® Joins Whil™ to Alleviate Financial Stress in the Workplace.
MSA partners with Whil, A Rethink Division, to support the number one cause of stress. ROSEVILLE, Calif.--(BUSINESS WIRE)--MSA today announced...
AXON Neuroscience Presented Results from its Phase II Clinical Trial Showing Multifold Therapeutic Effect of its Vaccine-Induced Antibodies at Eurotau2021
AXON presented results from its Phase II Clinical Study for AADvac1, vaccine against Alzheimer's presented at Eurotau2021AXON demonstrated that vaccination-induced...
Empower Clinics Opens Next The Medi-Collective Clinic in Mississauga
The Satellite Clinic Will Offer Family Medicine, Internal Medicine and Pharmacy ServicesVANCOUVER, BC / ACCESSWIRE / November 1, 2021 /...
InstadosePharma Announces Columbia JV and Supply Agreement
Instadose Pharma Announces Instadose Canada has Established Strategic Joint Venture Partnerships and a Supply Arrangement in Colombia for its Global...
The Merger of Dragon SPAC S.p.A. and Napo EU S.p.A. has Closed
The combined entity is named Napo EU S.p.A.SAN FRANCISCO, CA / ACCESSWIRE / November 1, 2021 / Jaguar Health, Inc....
NLS Pharmaceutics CEO Issues Letter to Shareholders
STANS, SWITZERLAND / ACCESSWIRE / November 1, 2021 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage...
Total Voting Rights
Total Voting Rights DUBLIN, Ireland, and Boston MA, November 1, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage biopharmaceutical...
CohBar to Announce 2021 Third Quarter Financial Results and Provide Business Update on November 15, 2021
Company to host conference call at 5:00 p.m. ETMENLO PARK, Calif., Nov. 01, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ:...
BioStem Technologies Announces Veterans Day Fundraiser to Support America’s VetDogs®
Pompano Beach, Fl., Nov. 01, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. and its subsidiary Blue Tech Industries, Inc. (d/b/a...
Anika Appoints Sheryl Conley to Board of Directors
Appointment brings experienced orthopedic industry commercial leader to Anika’s BoardBEDFORD, Mass., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc....
Revelation Biosciences Inc. Engages Partnering Advisor, MedWorld Advisors, to Optimize Value of the Company’s Diagnostic Tool, REVID™
-REVID may have use by individuals in at-home settings for rapid monitoring of respiratory viral infections- -Offering broad detection of...
atai Life Sciences Announces Supportive Interim Data from First 8-Patient Cohort of Phase 2a Trial for Novel Treatment of Cognitive Impairment Associated with Schizophrenia
These data have given atai confidence to support an accelerated clinical development timelineNEW YORK, Nov. 01, 2021 (GLOBE NEWSWIRE) --...
Sorrento’s License Partner, Lee’s Pharmaceutical Announces NDA Filing Acceptance by NMPA for Anti-PD-L1 Antibody Socazolimab for Treatment of Recurrent or Metastatic Cervical Cancer
Socazolimab is an anti-PD-L1 antibody licensed from Sorrento for the Greater China Territory by Lee’s Pharma.China National Medical Products Administration...
Vallon Pharmaceuticals Presents Data from Adult Stimulant Abuse Pattern Survey at the American Academy of Child and Adolescent Psychiatry (AACAP) 68th Annual Meeting
- Results suggest that developing stimulant formulations with abuse deterrent properties by non-oral routes may potentially reduce negative consequences of...
HMNC Brain Health Appoints Head of Regulatory Affairs
Dr. Katarina Jelic Maiboe brings significant global regulatory affairs experience to the executive management teamMUNICH, Nov. 01, 2021 (GLOBE NEWSWIRE)...
Minerva Neurosciences to Report Third Quarter 2021 Financial Results and Business Updates on November 8
Management to Host Conference CallWALTHAM, Mass., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company...